Clinical Trials in Pennsylvania

Showing 6041-6060 of 19,675 trials

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

NCT03646604

The objective of this study is to evaluate the safety, pharmacokinetics and tolerability of multiple doses of upadacitinib in pediatric participants with severe atopic dermatitis and to evaluate palatability of upadacitinib oral solution in pediatric participants.

Atopic Dermatitis

AbbVie35 participantsStarted Jan 2019

Huntington Beach, California, United States • Los Angeles, California, United States • Coral Gables, Florida, United States +15 more locations

Active Not RecruitingPhase 371 miles

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

NCT02914535

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in ulcerative colitis (UC).

Ulcerative Colitis

Alfasigma S.p.A.1,173 participantsStarted Feb 2017

Dothan, Alabama, United States • Scottsdale, Arizona, United States • Long Beach, California, United States +320 more locations

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Find Trials by Condition in Pennsylvania

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Different Doses of Naronapride Vs. Placebo in Gastroparesis

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

Framing Eighteen Coils in Cerebral Aneurysms Trial

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

Rituximab + Immunotherapy in Follicular Lymphoma

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

Comparative Effectiveness of Operative Versus Non-Operative Treatments for Rotator Cuff Tears

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors